These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6290049

  • 1. Doxorubicin-vincristine therapy for Wilms' tumor: a pilot study.
    Camitta B, Kun L, Glicklich M, Oechler H, Adair S, Pinkel D.
    Cancer Treat Rep; 1982 Oct; 66(10):1791-4. PubMed ID: 6290049
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Green DM, Breslow NE, Evans I, Moksness J, D'Angio GJ.
    Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
    Seseke F, Rebmann S, Zöller G, Lakomek M, Ringert RH.
    Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
    [Abstract] [Full Text] [Related]

  • 6. Invited comment on the Milwaukee pilot study of doxorubicin-vincristine therapy for Wilms' tumor.
    D'Angio G.
    Cancer Treat Rep; 1982 Oct; 66(10):1795-6. PubMed ID: 6290050
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D, National Wilms Tumor Study Group.
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH, Ritchey ML, Norkool PA, Takashima JR, Breslow NE, Green DM.
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B, Efferth T, Keller U, Beniers AJ, Mertens R, Jakse G, Füzesi L.
    Anticancer Res; 2001 Feb; 21(1B):771-6. PubMed ID: 11299842
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.